Recombinant interferon alfa 2 a in the treatment of patients with early stage B chronic lymphocytic leukaemia
- 1 September 1993
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 85 (1) , 77-83
- https://doi.org/10.1111/j.1365-2141.1993.tb08648.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Interferon alfa-2b in stage A untreated B-chronic lymphocytic leukaemia patientsEuropean Journal of Cancer and Clinical Oncology, 1991
- Maintenance therapy in the myeloproliferative disorders: the current optionsBritish Journal of Haematology, 1991
- Treatment of anti‐recombinant interferon‐alpha 2 antibody positive CML patients with natural interferon‐alphaBritish Journal of Haematology, 1991
- Interferon antibodies in patients with chronic HBV infection treated with recombinant interferonJournal of Hepatology, 1989
- Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon AntibodiesNew England Journal of Medicine, 1988
- Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia‐a pilot studyAmerican Journal of Hematology, 1987
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Management of CLL and Allied Disorders with Reference to Their Immunology and Proliferation KineticsPublished by Springer Nature ,1984
- Chronic Lymphocytic Leukaemia: Proposals for a Revised Prognostic Staging SystemBritish Journal of Haematology, 1981